Defensive ETFs Worth Buying: 3 Picks for March 2026
Market volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articlesMarket volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
If you want growth exposure without buying dozens of stocks, the Vanguard Growth ETF (VUG) could be a fit. This guide...
Intel prepares for a pivotal investor update, and investors want to know whether buying now makes sense. This guide b...
The market is navigating a phase many haven’t seen in a generation. Mega-cap tech dominates, valuations look stretche...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Many savers focus on how much to contribute and how to invest. But a hidden 401(k) option can dramatically improve yo...
Two popular U.S. dividend ETFs take different paths to income. This guide breaks down how SCHD and FDVV approach divi...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...
When a sudden death upends a family, money worries often follow. This article uses Nolan Wells’ Independent Autopsy a...